Related references
Note: Only part of the references are listed.Cationic Arginine-Rich Peptides (CARPs): A Novel Class of Neuroprotective Agents With a Multimodal Mechanism of Action
Bruno P. Meloni et al.
FRONTIERS IN NEUROLOGY (2020)
The Need for SMN-Independent Treatments of Spinal Muscular Atrophy (SMA) to Complement SMN-Enhancing Drugs
Niko Hensel et al.
FRONTIERS IN NEUROLOGY (2020)
Glial cells involvement in spinal muscular atrophy: Could SMA be a neuroinflammatory disease?
Elena Abati et al.
NEUROBIOLOGY OF DISEASE (2020)
Increased Skeletal Muscle Fiber Cross-Sectional Area, Muscle Phenotype Shift, and Altered Insulin Signaling in Rat Hindlimb Muscles in a Prenatally Androgenized Rat Model for Polycystic Ovary Syndrome
Auryana DeChick et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Advances in Treatment of Spinal Muscular Atrophy - New Phenotypes, New Challenges, New Implications for Care
David C. Schorling et al.
JOURNAL OF NEUROMUSCULAR DISEASES (2020)
Nusinersen: A Treatment for Spinal Muscular Atrophy
Melanie K. Claborn et al.
ANNALS OF PHARMACOTHERAPY (2019)
Molecular Mechanisms Underlying Sensory-Motor Circuit Dysfunction in SMA
Hannah K. Shorrock et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
Peptide-conjugate antisense based splice-correction for Duchenne muscular dystrophy and other neuromuscular diseases
Maria K. Tsoumpra et al.
EBIOMEDICINE (2019)
Age-dependent SMN expression in disease-relevant tissue and implications for SMA treatment
Daniel M. Ramos et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Clinical Evidence Supporting Early Treatment Of Patients With Spinal Muscular Atrophy: Current Perspectives
Tamara Dangouloff et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2019)
Molecular Factors Involved in Spinal Muscular Atrophy Pathways as Possible Disease-modifying Candidates
Marianna A. Maretina et al.
CURRENT GENOMICS (2018)
Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy
E. Mercuri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Advances in spinal muscular atrophy therapeutics
Valeria Parente et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2018)
Identification of a Peptide for Systemic Brain Delivery of a Morpholino Oligonucleotide in Mouse Models of Spinal Muscular Atrophy
Fazel Shabanpoor et al.
NUCLEIC ACID THERAPEUTICS (2017)
Pro-death NMDA receptor signaling is promoted by the GIuN2B C-terminus independently of Dapk1
Jamie McQueen et al.
ELIFE (2017)
Advances in modeling and treating spinal muscular atrophy
Meaghan Van Alstyne et al.
CURRENT OPINION IN NEUROLOGY (2016)
The neuromuscular impact of symptomatic SMN restoration in a mouse model of spinal muscular atrophy
W. Arnold et al.
NEUROBIOLOGY OF DISEASE (2016)
Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy
Suzan M. Hammond et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Neuromuscular Junctions as Key Contributors and Therapeutic Targets in Spinal Muscular Atrophy
Marina Boido et al.
FRONTIERS IN NEUROANATOMY (2016)
Development and Application of an Ultrasensitive Hybridization-Based ELISA Method for the Determination of Peptide-Conjugated Phosphorodiamidate Morpholino Oligonucleotides
Umar Burki et al.
NUCLEIC ACID THERAPEUTICS (2015)
Expression of Muscle-Specific MiRNA 206 in the Progression of Disease in a Murine SMA Model
Valeria Valsecchi et al.
PLOS ONE (2015)
Effect of Combined Systemic and Local Morpholino Treatment on the Spinal Muscular Atrophy Δ7 Mouse Model Phenotype
Monica Nizzardo et al.
CLINICAL THERAPEUTICS (2014)
Intravenous AAV9 efficiently transduces myenteric neurons in neonate and juvenile mice
Sara E. Gombash et al.
Frontiers in Molecular Neuroscience (2014)
Cell-Penetrating Peptide-Mediated Therapeutic Molecule Delivery into the Central Nervous System
Li-Li Zou et al.
CURRENT NEUROPHARMACOLOGY (2013)
Antisense Oligonucleotides for the Treatment of Spinal Muscular Atrophy
Paul N. Porensky et al.
HUMAN GENE THERAPY (2013)
Selective Vulnerability of Spinal and Cortical Motor Neuron Subpopulations in delta7 SMA Mice
Paolo d'Errico et al.
PLOS ONE (2013)
Dysregulation of synaptogenesis genes antecedes motor neuron pathology in spinal muscular atrophy
Zhenxi Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model
Yimin Hua et al.
NATURE (2011)
Spinal muscular atrophy
Adele D'Amico et al.
ORPHANET JOURNAL OF RARE DISEASES (2011)
Morpholinos and their peptide conjugates: Therapeutic promise and challenge for Duchenne muscular dystrophy
Hong M. Moulton et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2010)
Cell penetrating peptide conjugates of steric block oligonucleotides
Bernard Lebleu et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy
Shingo Kariya et al.
HUMAN MOLECULAR GENETICS (2008)
Sustained dystrophin expression induced by peptide-conjugated morpholino oligomers in the muscles of mdx mice
Natee Jearawiriyapaisarn et al.
MOLECULAR THERAPY (2008)
Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer
Bo Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Cell-penetrating peptides for drug delivery across membrane barriers
Camilla Foged et al.
EXPERT OPINION ON DRUG DELIVERY (2008)
Morpholino oligomer -: Mediated Exon skipping averts the onset of dystrophic pathology in the mdx mouse
Sue Fletcher et al.
MOLECULAR THERAPY (2007)
Abnormal motor phenotype in the SMNΔ7 mouse model of spinal muscular atrophy
Matthew E. R. Butchbach et al.
NEUROBIOLOGY OF DISEASE (2007)
Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents
Said Abes et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Properties of cell penetrating peptides (CPPs)
A Kerkis et al.
IUBMB LIFE (2006)
SMNΔ7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN
TT Le et al.
HUMAN MOLECULAR GENETICS (2005)
Role of insulin-like growth factor I signaling in neurodegenerative diseases
JL Trejo et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2004)
HIV Tat peptide enhances cellular delivery of antisense morpholino oligomers
HM Moulton et al.
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT (2003)
Share Paper
